{"id":13952,"date":"2019-04-28T15:46:21","date_gmt":"2019-04-28T19:46:21","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/resources\/all-resources\/pcpa-brand-practice-guidelines\/"},"modified":"2022-06-28T15:55:22","modified_gmt":"2022-06-28T19:55:22","slug":"pcpa-brand-practice-guidelines","status":"publish","type":"resource","link":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/","title":{"rendered":"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":13959,"template":"","resource-category":[225],"resource-tag":[],"resource-type":[150],"topic":[238],"team-member-id":[],"class_list":["post-13952","resource","type-resource","status-publish","has-post-thumbnail","hentry","resource-category-liens-connexes","resource-type-lien","topic-acces-aux-medicaments"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-28T19:55:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/\",\"name\":\"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/pcpa_brand_process_guidelines_fr-1-pdf.jpg\",\"datePublished\":\"2019-04-28T19:46:21+00:00\",\"dateModified\":\"2022-06-28T19:55:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/pcpa_brand_process_guidelines_fr-1-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/pcpa_brand_process_guidelines_fr-1-pdf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/pcpa-brand-practice-guidelines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ressources\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Toutes les ressources\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/ressources\\\/toutes-les-ressources\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/","og_locale":"fr_FR","og_type":"article","og_title":"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada","og_url":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2022-06-28T19:55:22+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/","url":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/","name":"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2019\/04\/pcpa_brand_process_guidelines_fr-1-pdf.jpg","datePublished":"2019-04-28T19:46:21+00:00","dateModified":"2022-06-28T19:55:22+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2019\/04\/pcpa_brand_process_guidelines_fr-1-pdf.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2019\/04\/pcpa_brand_process_guidelines_fr-1-pdf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/pcpa-brand-practice-guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Ressources","item":"https:\/\/innovativemedicines.ca\/fr\/ressources\/"},{"@type":"ListItem","position":3,"name":"Toutes les ressources","item":"https:\/\/innovativemedicines.ca\/fr\/ressources\/toutes-les-ressources\/"},{"@type":"ListItem","position":4,"name":"Lignes directrices du processus de n\u00e9gociation des m\u00e9dicaments novateurs l\u2019APP"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/resource\/13952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/resource"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/13959"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=13952"}],"wp:term":[{"taxonomy":"resource-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/resource-category?post=13952"},{"taxonomy":"resource-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/resource-tag?post=13952"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/resource-type?post=13952"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=13952"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=13952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}